miR-299-3p suppresses cell progression and induces apoptosis by downregulating PAX3 in gastric cancer
Gastric cancer (GC) is ranked the fourth leading cause of cancer-related death, with an over 75% mortality rate worldwide. In recent years, miR-299-3p has been identified as a biomarker in multiple cancers, such as acute promyelocytic leukemia, thyroid cancer, and lung cancer. However, the regulator...
Guardado en:
Autores principales: | Wang Zhenfen, Liu Qing, Huang Ping, Cai Guohao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/db7eeb1c2e1741b896d847ce81510c5f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Regulation of Pax7 protein levels by caspase-3 and proteasome activity in differentiating myoblasts
por: Olguín,Hugo C
Publicado: (2011) -
Targeting Oncogenic miR-181a-2-3p Inhibits Growth and Suppresses Cisplatin Resistance of Gastric Cancer
por: Jin L, et al.
Publicado: (2021) -
LncRNA LINC00483 promotes gastric cancer development through regulating MAPK1 expression by sponging miR-490-3p
por: Luo,Min, et al.
Publicado: (2020) -
Expression of Pax6 and Pax7 Proteins During the Central Nervous System Development in Human Embryos
por: Namm,Aimar, et al.
Publicado: (2020) -
The diagnostic and prognostic value of miR-92a in gastric cancer: A systematic review and meta-analysis
por: Guo Hanxu, et al.
Publicado: (2021)